Biotechnology

Healthcare AI’s next test is integration

The entrance of major AI companies into healthcare is a meaningful and welcome d...

Microscale Chromatography Moves Toward Manufacturing Re...

AstraZeneca researchers show that automated microscale chromatography can genera...

No One-Size-Fits-All Solution for Autologous Cell Thera...

The operational challenges of making patient-specific cell therapies require car...

Increasing CHO Cell Productivity

Overexpressing the gene Pabpc1 in CHO cell cultures increases productivity by 30...

Monoclonal Antibodies Targeting MMP-9 Alleviate Periphe...

Scientists developed monoclonal antibodies targeting matrix metalloproteinase-9,...

Gene Therapy Extends Lifespan and Reduces Symptoms in S...

Intravenous gene therapy extended lifespan, reduced neurological symptoms, and i...

The Emerging Power of Mass Spectrometry in Oncology

Novel approaches are urgently needed to improve availability of diagnostic assay...

Novartis Shares Slide After Neuromuscular Candidate Acq...

Del-desiran failed the Phase III HARBOR trial (NCT06411288) by missing the study...

NRAS Mutations May Require Mutation-Guided Combination ...

Mutant NRAS has remained difficult to target in cancer. New findings suggest tha...

ADCs, mAbs, CAR Ts: One Bioluminescent Platform Measure...

The HiBiT Target Cell Killing (TCK) platform, with off-the-shelf, mix-and-match ...

The Multi-Attribute Method (MAM) as a Biologics Lifecyc...

A more coherent approach: a peptide-mapping LC-HRMS (liquid chromatography-high ...

RNAV8 Bio Joins ARPA-H Team to Pioneer Programmable RNA...

The PROPEL program aims to control gene expression through RNA structure, buildi...

Regenerative Medicine in the Bronze Age: MSCs and MSC-E...

The field of regenerative medicine is gaining momentum. Mesenchymal stem cells (...

Anticancer Candidate Strengthens Bones and Prevents Wei...

A preclinical study in post-menopausal bone loss mouse models found that CADD522...

ProBioGen Grants Transgene Additional License for AGE1....

ProBioGen’s AGE1.CR.pIX is a stable proliferating avian cell line derived from d...

Targeted Lentiviral Delivery Without Vector Reengineering

Rather than requiring genetic modification of the viral glycoprotein, G-Link use...